Breast cancer treatment depends on the stage of the disease, tumor characteristics, hormone receptor status, HER2 status, overall health, and individual treatment goals. Early stage breast cancer may be treated with surgery, radiation therapy, hormone therapy, chemotherapy, or targeted medicines, depending on the clinical situation. Advanced breast cancer may require systemic treatments
Breast cancer develops when abnormal cells in breast tissue grow uncontrollably. Doctors determine its stage by evaluating tumor size, lymph node involvement, and whether the cancer has spread to other parts of the body. Treatment planning also considers biomarkers, including estrogen receptors, progesterone receptors, and HER2. Because these factors influence treatment selection, two people with the same stage may receive different treatment plans. A multidisciplinary team may include surgeons, medical oncologists, radiation oncologists, pathologists, and other specialists.
Treatment approaches vary according to the extent of the disease and its biological characteristics. Early stage breast cancer is generally confined to the breast or nearby lymph nodes, while advanced disease may involve distant organs. Doctors combine treatments when appropriate to remove cancer, reduce recurrence risk, or control its growth.
Common treatment approaches include:
Stage 0: Ductal carcinoma in situ may be managed with breast-conserving surgery or mastectomy, depending on the extent of the abnormal cells. Radiation therapy and hormone therapy may be recommended in selected cases.
Stage I: Treatment often includes surgery, such as lumpectomy or mastectomy. Radiation may follow breast-conserving surgery, while hormone therapy, chemotherapy, or targeted therapy may be considered according to tumor characteristics and recurrence risk.
Stage II: Surgery is frequently combined with additional treatments. Some patients receive chemotherapy or other systemic treatment before surgery to shrink the tumor, while others receive treatment afterward.
Stage III: This locally advanced disease often requires a combination of systemic therapy, surgery, and radiation. Treatment may begin with chemotherapy, targeted therapy, or other appropriate medicines before surgery.
Stage IV: Also called metastatic breast cancer, this stage means the disease has spread to distant parts of the body. Treatment generally focuses on controlling cancer, relieving symptoms, preserving quality of life, and extending survival. Options may include hormone therapy, targeted therapy, chemotherapy, immunotherapy for eligible patients, and selected radiation or surgical procedures.
The choice of treatment depends on cancer subtype, test results, previous treatments, and the person's overall health. Clinical trials may also provide access to investigational approaches for eligible patients.
Advanced breast cancer can include locally advanced disease that has not spread to distant organs and metastatic disease that has. Recurrent breast cancer refers to cancer that returns after treatment. Recurrence may occur in the breast, nearby tissues, lymph nodes, or distant organs. Doctors reassess the disease because its characteristics may differ from those identified during the original diagnosis.
Treatment options may include:
Hormone therapy: Used for hormone receptor positive cancers to slow or stop cancer growth.
HER2 targeted therapy: Medicines targeting HER2 may be used for cancers that produce excess HER2 protein or have HER2 gene amplification.
Chemotherapy: May be recommended when cancer is aggressive, has spread, or requires a treatment approach that works throughout the body.
Immunotherapy: Certain patients with specific breast cancer subtypes and biomarker results may qualify for immunotherapy.
Radiation therapy: Can help control cancer in particular areas and relieve symptoms, including pain caused by bone involvement.
Clinical trials: Eligible patients may consider studies evaluating new medicines, combinations, or treatment strategies.
For recurrent disease, doctors may repeat biopsies or biomarker testing when feasible to guide treatment selection. Previous therapies, the time since treatment, the location of recurrence, and treatment-related side effects all influence decisions. Supportive care can help manage pain, fatigue, emotional distress, and other symptoms throughout treatment.
Breast cancer treatment continues to evolve as research improves understanding of tumor biology and treatment response. Patients should discuss the benefits, risks, possible side effects, and goals of each recommended approach with their oncology team. Regular follow-up and individualized care planning remain important throughout treatment and recovery.